IDEAYA Biosciences, Inc.

IDYA·NasdaqGS·Healthcare
Compare
32.36+1.03 (+3.29%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close31.33
Open31.97
Day range31.4432.36
52-week range26.8142.68
Off day high0.00%
Off 52-week high−24.18%
Volume1.90M
Avg. volume (3M)834.15K
Market cap3.12B
EPS (TTM)-4.50
Forward P/E-7.93
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.08
Shares outstanding96.49M
Short interest10.93% of float
Earnings dateNov 3, 2026
Analyst target51.92
Profit margin−74.75%

Against its peers

Compare in full ›
IDYA RCUS 9966.HK 688382.SS 2256.HK IMCR
Market cap 3.12B 2.43B 6.43B 8.38B 5.03B 1.51B
P/E (TTM) — — — — — —
Forward P/E -7.9 -6.2 -21.0 -43.8 -24.1 -37.7
Price/book 2.9 3.8 3.3 6.6 2.0 3.6
Dividend yield — — — — — —
1-year change +5.63% −4.25% −39.84% −48.70% −54.94% −2.50%
Today +3.29% +2.12% +1.68% +4.33% +6.85% −2.66%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IDYA news ›
Stock Titan·Positive

IDEAYA Biosciences CEO sells 26,338 shares

3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finland J-Star Holding Co., Ltd. Advances U.S. Drone Manufacturing Initiative; Negotiates Acquisition of Facility in the Greater Houston Area Merck…

@PRNewswire·Positive

IDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanoma

Oct 19, 2026, 06:00 ET Prior tebentafusp (2L) (N=15) All presentations will take place on Saturday, October 24th, 2026, 12:00-12:45pm (CEST): 2092P (Poster Presentation)Title: Neoadjuvant Darovasertib in Primary Uveal Melanoma: Follow-Up…

From the 4Search news index, newest first.

In the news

8mentions in 30 days
8with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 8 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance